CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. | Carcinogenesis;35(2): 461-8, 2014 Feb. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.

Pannem, Rajeswara Rao; Dorn, Christoph; Ahlqvist, Kristofer; Bosserhoff, Anja K; Hellerbrand, Claus; Massoumi, Ramin.

Affiliation

Pannem RR; Department of Laboratory Medicine, Skåne University Hospital, Lund University, Malmö SE-20502, Sweden.

Carcinogenesis ; 35(2): 461-8, 2014 Feb.

Article in En | MEDLINE | ID: mdl-24104553

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cysteine Endopeptidases / Proto-Oncogene Proteins c-myc / Carcinoma, Hepatocellular / Tumor Suppressor Proteins / Mitogen-Activated Protein Kinase 8 / Liver Neoplasms Limits: Animals / Humans / Male Language: En Journal: Carcinogenesis Year: 2014 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cysteine Endopeptidases / Proto-Oncogene Proteins c-myc / Carcinoma, Hepatocellular / Tumor Suppressor Proteins / Mitogen-Activated Protein Kinase 8 / Liver Neoplasms Limits: Animals / Humans / Male Language: En Journal: Carcinogenesis Year: 2014 Document type: Article Affiliation country: Country of publication: